NASDAQ : MRKR
Marker Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.98 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Marker Therapeutics, Inc. (MRKR) reported revenue of 3.55M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.55M | 3.55M | 6.59M | 3.31M | 3.51M | 1.24M |
| Cost of Revenue | 8.81M | 11.80M | 13.47M | 10.42M | 11.97M | 27.79M |
| Gross Profit | -5.26M | -8.25M | -6.88M | -7.11M | -8.45M | -26.55M |
| Selling, General & Admin | 4.24M | 4.18M | 4.24M | 7.48M | 11.34M | 12.92M |
| Operating Expenses | 4.24M | 4.18M | 4.24M | 7.48M | 11.34M | 12.92M |
| Operating Income | -9.50M | -12.44M | -11.12M | -14.58M | -19.79M | -39.48M |
| Interest & Investment Income | 549.14K | 594.21K | 437.01K | 539.16K | 248.06K | 5.70K |
| Other Non Operating Income (Expenses) | 231.66K | 117.44K | ||||
| EBT Excluding Unusual Items | -8.72M | -11.73M | -10.68M | -14.04M | -19.54M | -39.47M |
| Other Unusual Items | -453.13K | -232.97K | -2.41M | |||
| Pretax Income | -8.72M | -12.18M | -10.68M | -14.04M | -19.78M | -41.88M |
| Income Tax Expense | -15.16K | -15.16K | 49.95K | 3.67K | ||
| Earnings From Continuing Operations | -8.71M | -12.16M | -10.73M | -14.05M | -19.78M | -41.88M |
| Earnings From Discontinued Operations | 5.81M | -10.15M | ||||
| Net Income | -8.71M | -12.16M | -10.73M | -8.24M | -29.93M | -41.88M |
| Net Income to Common | -8.71M | -12.16M | -10.73M | -8.24M | -29.93M | -41.88M |
| Shares Outstanding (Basic) | 18.70M | 15.31M | 8.98M | 8.81M | 8.35M | 7.65M |
| Shares Outstanding (Diluted) | 18.70M | 15.31M | 8.98M | 8.81M | 8.35M | 7.65M |
| EPS (Basic) | -0.47 | -0.79 | -1.19 | -0.94 | -3.58 | -5.47 |
| EPS (Diluted) | -0.47 | -0.79 | -1.19 | -0.94 | -3.59 | -5.47 |
| Free Cash Flow | -9.76M | -12.01M | -10.91M | -16.44M | -26.97M | -30.41M |
| Free Cash Flow Per Share | -0.52 | -0.79 | -1.22 | -1.87 | -3.23 | -3.98 |
| Gross Margin | -148.28% | -232.68% | -104.33% | -214.60% | -240.64% | |
| Operating Margin | -267.95% | -350.67% | -168.69% | -440.37% | -563.28% | -3,179.32% |
| Profit Margin | -245.51% | -342.96% | -162.82% | -248.76% | -851.87% | -3,372.68% |
| Free Cash Flow Margin | -275.09% | -338.74% | -165.53% | -496.51% | -767.66% | -2,449.11% |
| EBITDA | -11.79M | -17.00M | -37.33M | |||
| D&A For EBITDA | 2.79M | 2.79M | 2.15M | |||
| EBIT | -9.50M | -12.44M | -11.12M | -14.58M | -19.79M | -39.48M |
| EBIT Margin | -267.95% | -168.69% | ||||
| Revenue as Reported | 3.55M | 3.55M | 6.59M | 3.31M | 3.51M | 1.24M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 11.33M | 16.07M | 19.19M | 15.11M | 11.78M | 42.35M |
| Cash & Short-Term Investments | 11.33M | 16.07M | 19.19M | 15.11M | 11.78M | 42.35M |
| Other Receivables | 1.62M | 1.37M | 2.35M | 1.03M | 2.40M | 237.00 |
| Receivables | 1.62M | 1.37M | 2.35M | 1.03M | 2.40M | 237.00 |
| Prepaid Expenses | 1.04M | 658.75K | 483.72K | 988.13K | 1.85M | 2.48M |
| Restricted Cash | 591.31K | 974.80K | 1.15M | |||
| Other Current Assets | 585.84K | |||||
| Total Current Assets | 14.59M | 19.07M | 22.02M | 17.13M | 16.62M | 45.98M |
| Property, Plant & Equipment | 22.15M | |||||
| Other Long-Term Assets | 17.80M | |||||
| Total Assets | 14.59M | 19.07M | 22.02M | 17.13M | 34.42M | 68.14M |
| Accounts Payable | 585.04K | 793.73K | 1.07M | 961.00K | 1.10M | 5.14M |
| Accrued Expenses | 1.04M | 301.73K | 2.19M | 1.91M | 1.27M | 3.33M |
| Current Portion of Leases | 620.49K | |||||
| Current Unearned Revenue | 591.31K | 974.80K | 1.15M | |||
| Other Current Liabilities | 204.18K | 203.93K | 203.43K | 205.19K | 5.41M | 2.66M |
| Total Current Liabilities | 2.42M | 2.27M | 3.46M | 3.07M | 7.78M | 12.90M |
| Long-Term Leases | 11.25M | |||||
| Other Long-Term Liabilities | 7.04M | |||||
| Total Liabilities | 2.42M | 2.27M | 3.46M | 3.07M | 14.82M | 24.15M |
| Common Stock | 16.67K | 16.67K | 10.71K | 8.89K | 8.41K | 8.31K |
| Additional Paid-In Capital | 476.34M | 475.96M | 465.56M | 450.33M | 447.64M | 442.10M |
| Retained Earnings | -464.19M | -459.18M | -447.02M | -436.29M | -428.05M | -398.12M |
| Shareholders' Equity | 12.17M | 16.80M | 18.56M | 14.05M | 19.60M | 43.99M |
| Total Liabilities & Equity | 14.59M | 19.07M | 22.02M | 17.13M | 34.42M | 68.14M |
| Total Debt | 11.87M | |||||
| Net Cash (Debt) | 11.33M | 16.07M | 19.19M | 15.11M | 11.78M | 30.48M |
| Net Cash Per Share | 0.61 | 1.05 | 2.14 | 1.72 | 1.41 | 3.98 |
| Filing Date Shares Outstanding | 16.67M | 16.67M | 10.71M | 8.90M | 8.80M | 8.31M |
| Total Common Shares Outstanding | 16.67M | 16.67M | 10.71M | 8.89M | 8.41M | 8.31M |
| Working Capital | 12.17M | 16.80M | 18.56M | 14.05M | 8.84M | 33.08M |
| Book Value Per Share | 0.73 | 1.01 | 1.73 | 1.58 | 2.33 | 5.29 |
| Tangible Book Value | 12.17M | 16.80M | 18.56M | 14.05M | 19.60M | 43.99M |
| Tangible Book Value Per Share | 0.73 | 1.01 | 1.73 | 1.58 | 2.33 | 5.29 |
| Machinery | 9.66M | |||||
| Construction In Progress | 2.23M | |||||
| Leasehold Improvements | 3.17M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -8.71M | -12.16M | -10.73M | -8.24M | -29.93M | -41.88M |
| Depreciation & Amortization | 3.16M | |||||
| Stock-Based Compensation | 518.57K | 537.54K | 245.86K | 858.27K | 3.30M | 5.96M |
| Other Operating Activities | -5.81M | -278.68K | ||||
| Change in Accounts Receivable | 54.86K | 977.30K | -1.32M | 1.37M | -2.40M | 1.00M |
| Change in Accounts Payable | -1.24M | -454.57K | 8.76K | -718.39K | -1.32M | 4.14M |
| Change in Unearned Revenue | -761.67K | 974.80K | -1.15M | 1.15M | ||
| Change in Other Net Operating Assets | 383.08K | -1.89M | 885.25K | 2.19M | 104.15K | -815.50K |
| Operating Cash Flow | -9.76M | -12.01M | -10.91M | -16.44M | -26.97M | -27.28M |
| Capital Expenditures | -3.13M | |||||
| Other Investing Activities | 18.66M | -4.95M | ||||
| Investing Cash Flow | 18.66M | -4.95M | -3.13M | |||
| Issuance of Common Stock | 9.86M | 9.86M | 14.99M | 1.11M | 202.13K | 52.56M |
| Financing Cash Flow | 9.86M | 9.86M | 14.99M | 1.11M | 202.13K | 52.56M |
| Net Cash Flow | 107.39K | -2.15M | 4.08M | 3.33M | -31.72M | 22.14M |
| Free Cash Flow | -9.76M | -12.01M | -10.91M | -16.44M | -26.97M | -30.41M |
| Free Cash Flow Margin | -275.09% | -338.74% | -165.53% | -496.51% | -767.66% | -2,449.11% |
| Free Cash Flow Per Share | -0.52 | -0.79 | -1.22 | -1.87 | -3.23 | -3.98 |
| Levered Free Cash Flow | -6.23M | -8.60M | -7.13M | -10.14M | -14.77M | -12.98M |
| Unlevered Free Cash Flow | -6.23M | -8.60M | -7.13M | -10.14M | -14.77M | -12.98M |
| Change in Working Capital | -1.57M | -388.00K | -424.87K | 2.85M | -4.76M | 5.47M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 15.02M | 24.84M | 33.30M | 48.89M | 22.71M | 78.94M |
| Enterprise Value | 3.69M | 7.25M | 24.30M | 31.42M | 12.35M | 42.25M |
| Last Close Price | 0.90 | 1.49 | 3.11 | 5.50 | 2.66 | 9.50 |
| PS Ratio | 4.24 | 7.00 | 5.05 | 14.77 | 6.46 | 63.58 |
| PB Ratio | 1.23 | 1.48 | 1.79 | 3.48 | 1.16 | 1.79 |
| P/TBV Ratio | 1.23 | 1.48 | 1.79 | 3.48 | 1.16 | 1.79 |
| EV/Sales Ratio | 1.04 | 2.04 | 3.69 | 9.49 | 3.52 | 34.02 |
| Debt / Equity Ratio | 0.27 | |||||
| Net Debt / Equity Ratio | -0.93 | -0.96 | -1.03 | -1.07 | -0.60 | -0.69 |
| Net Debt / EBITDA Ratio | 1.28 | 0.69 | 0.82 | |||
| Net Debt / FCF Ratio | 1.16 | 1.34 | 1.76 | 0.92 | 0.44 | 1.00 |
| Asset Turnover | 0.24 | 0.17 | 0.34 | 0.13 | 0.07 | 0.02 |
| Quick Ratio | 5.35 | 7.67 | 6.22 | 5.25 | 1.82 | 3.28 |
| Current Ratio | 6.03 | 8.39 | 6.36 | 5.57 | 2.14 | 3.56 |
| Return on Equity (ROE) | -76.87% | -68.81% | -65.81% | -83.47% | -62.20% | -117.42% |
| Return on Assets (ROA) | -40.47% | -37.83% | -35.50% | -35.36% | -24.12% | -43.38% |
| Return on Capital Employed (ROCE) | -78.10% | -74.00% | -59.90% | -103.80% | -74.30% | -71.50% |
| Earnings Yield | -51.73% | -48.96% | -32.23% | -16.85% | -131.80% | -53.05% |
| FCF Yield | -64.94% | -48.36% | -32.76% | -33.63% | -118.78% | -38.52% |
| Buyback Yield / Dilution | -73.22% | -70.49% | -1.94% | -5.49% | -9.16% | -62.64% |